跳至主要内容
临床试验/JPRN-jRCT1061200041
JPRN-jRCT1061200041招募中未知

The investigation for the usefulness of carnitine medication in patients with decompensated liver cirrhosis - The usefulness of carnitine medication in patients with decompensated liver cirrhosis

Takaki Akinobu0 个研究点目标入组 60 人开始时间: 2020年12月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • The decompensated liver cirrhosis patients with
  • Child-Pugh score over 7 points, and satisfy the following
  • 1. over 20 years old
  • 2. written informed consent
  • 3. can periodically go to hospital

排除标准

  • 1. already take carinitine
  • 2. The blood concentration of total carinitine and
  • free carinitine is higher than the normal upper
  • limit value
  • 3. with a history of any hypersensitivity to ingredients in
  • L-Cartin FF tablets and Levocarnitine FF tablets.
  • 4. pregnant, unwilling to practice contraception during
  • 5.. lactating female
  • 6. The patient who received other study medicine
  • or the clinical experimental medicine within three
  • months before start of this study
  • 7. The investigator judged to be inappropriate as the study

研究者

发起方
Takaki Akinobu

相似试验